The application value of plasma PCSK9 in the prediction of 28-day mortality risk of sepsis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026452

Enrollment

Unknown

Registered

2019-10-10

Start date

2019-10-14

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Sepsis chock

Interventions

Case group:N/A

Control group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients with sepsis or sepsis chock met diagnosis standard of sepsis-3.0; (2) Aged > 18 years old.

Exclusion criteria

Exclusion criteria: (1) Pregnant woman; (2) Patients who died within 24 hours; (3) Complicated with malignant tumors; (4) Complicated with immunosuppressive disease(AIDS).

Design outcomes

Primary

Measure	Time frame
28-day all-cause mortality;	—

Secondary

Measure	Time frame
Total length of hospital stay;Length of hospital stay in ICU;Organ support and growth;1 week of organ failure;SOFA score;	—

Countries

China

Contacts

Public ContactQiu Chengfeng

The First People's Hospital of Huaihua

qiuchengfeng0721@163.com+86 14786531725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026